Boris Peaker, Ph.D., CFA

Managing Director, Health Care - Biotechnology

Headshot photo of Boris Peaker

Boris Peaker is a managing director and senior research analyst covering emerging growth biotechnology companies. Prior to rejoining Cowen in 2014, Dr. Peaker was a senior analyst at Oppenheimer & Co. and Rodman & Renshaw, covering large-, mid-, and small-cap biotechnology stocks. Dr. Peaker holds a BS in physics and chemistry from Stony Brook University and a Ph.D. in biophysics from Stanford University. He is a CFA charterholder. HCBiopharma

Get In Touch

Start a conversation with Boris Peaker


    Explore related thought leadership, reports, coverage and insights for Boris Peaker.


    ESG Best Ideas 2022

    Read More >
    Ahead of the Curve®

    ABCs of ADCs: Investor Primer on Antibody Drug Conjugates

    Read More >
    Ahead of the Curve®

    An Investor’s Guide to Bispecific Antibodies

    Read More >

    Research Contacts

    Our Research team is led by seasoned, entrepreneurial-minded individuals who are driven by a relentless curiosity to redefine expectations.

    Meet Our People
    Senior businessman handshaking with young woman in the office